OpenAlex
PricingAboutJobs
Log inGet started
Work

Methylation of the DPYD Promoter: An Alternative Mechanism for Dihydropyrimidine Dehydrogenase Deficiency in Cancer Patients

HTML

Year: 2005
Type: article
Study design: Observational Study
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-05-1520
Authors: Hany H. Ezzeldin, Adam M. Lee, Lori K. Mattison, Robert B. Diasio
Institution: University of Alabama at Birmingham
Language: English

Topic: Pharmacogenetics and Drug Metabolism
Subfield: Pharmacology
Field: Pharmacology, Toxicology and Pharmaceutics
Domain: Life Sciences
Keywords: dihydropyrimidine dehydrogenase deficiency, epigenetic silencing, 5-fluorouracil toxicity, pharmacogenetics, cancer patients, DPYD*2A, gene expression regulation
SDG: Good health and well-being

Open Access status: closed

Funders: University of Alabama at Birmingham, National Cancer Institute
Awards: Genetic Polymorphism of Dihydropyrimidine Dehydrogenase, Molecular Approach in Predicting 5-Fluorouracil Efficacy
OpenAlex ID: W2149894474
FWCI: 4.577
Cites: 26
Cited by: 108
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security